title: Changing the conversation regarding pediatric cholesterol screening: the rare disease paradigm.
authors.affiliation: Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts 02215, USA. matthew_gillman@hms.harvard.edu
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Gillman
mesh_terms: D000293:Adolescent; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood / Q000175:diagnosis / Q000517:prevention & control*; D002648:Child; D002784:Cholesterol / Q000097:blood*; D006291:Health Policy; D006801:Humans; D008403:Mass Screening / Q000009:adverse effects / Q000941:ethics / Q000379:methods / Q000592:standards; D017410:Practice Guidelines as Topic; D035583:Rare Diseases / Q000097:blood / Q000175:diagnosis*; D014481:United States
chemical_list: D015415:Biomarkers; D002784:Cholesterol